Potential impact of Teledermatology on NHS backlogs – The case for adoption
This report was commissioned and funded by AbbVie. Summary [...]
Value-based agreements: the future of life sciences deals in the UK?
Innovation and disruption in life sciences (LS) and healthcare [...]
Creating Collaborative Opportunities for Life Sciences in NHS Integrated Care Systems
1. How can Lifesciences Partner Effectively with ICSs? Many [...]
What will it mean to improve outcomes for lung cancer patients?
Every four minutes someone in the UK dies from cancer, [...]
Building analytical tools to support COVID-19 capacity planning in London
CF supported NHS London in developing a suite of [...]
Data strategy for digital devices
CF supported a global life science company to generate [...]
Data enabled clinical trials
The Government of a European nation with a strong [...]
Landscape review of the UKRI data research infrastructure
UK Research and Innovation (UKRI), including the seven research [...]
Identifying opportunities and understanding the benefits of pathway optimisation
CF worked on behalf of a global pharmaceutical company [...]
Improving the cancer pathway from the impact of Covid-19
CF has been working with a large international pharmaceutical client [...]
